MedTrace Logo

Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers

NCT01771627 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2020-09-28

Study results available
· View outcomes & findings →

Summary

This pilot clinical trial studies varenicline or nicotine patch in promoting smoking cessation among current smokers. Varenicline or nicotine patch may help people stop smoking

Conditions

  • Tobacco Use Disorder

Interventions

DRUG

varenicline

Given PO

DRUG

nicotine patch

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Roswell Park Cancer Institute

    lead OTHER

Principal Investigators

  • Martin Mahoney · Roswell Park Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-22
Primary Completion
2014-09-28
Completion
2015-08-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01771627 on ClinicalTrials.gov